11 Apr 2012
A postdoctoral position is available in the Brisken group to study the mechanisms by which oestrogen and progesterone receptor signalling promote breast carcinogenesis in vivo. In close collaboration with clinical partners innovative xenograft models and ex vivo approaches are developed in the laboratory. Lentiviral technology will be used to modulate in vivo gene function.
Applicants must hold a PhD in the field of molecular biology, developmental or cancer biology, or biochemistry and have a demonstrated track record of innovative scientific publications. The initial contract is for one year, with the possibility of an extension to four years. Please send your application as a single PDF, including a letter of motivation, CV and contact info of 2-3 referees to [email protected]. Click on the link below for more information. The closing date for applications is 4 May 2012.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024